Literature DB >> 2588210

Bronchoalveolar lavage cell counts as a predictor of short term outcome in pulmonary sarcoidosis.

N M Foley1, A P Coral, K Tung, B N Hudspith, D G James, N M Johnson.   

Abstract

Sixty seven patients with biopsy proven pulmonary sarcoidosis were prospectively studied to determine whether single point bronchoalveolar lavage cell counts were a useful indicator of functional outcome and whether repeated lavage helped in management. The mean follow up period was 25 (range 13-37) months. No patient was having corticosteroid treatment at the time of initial bronchoalveolar lavage. "High intensity alveolitis" (lymphocyte count greater than or equal to 28%) was present at the initial lavage in 42 patients. These patients showed a significant improvement in their pulmonary function and chest radiographs over the follow up period whereas patients with "low intensity alveolitis" did not. Of the 42 patients with high intensity alveolitis, 31 had chronic sarcoidosis (duration over two years, mean 80 months). These patients showed a significant improvement in FVC but not in TLCO. Corticosteroids resulted in greater functional and radiological improvement in the patients with high intensity alveolitis than in those with low intensity alveolitis. Repeat bronchoalveolar lavage in 34 patients, mean 8.4 months after the original lavage, showed a weak inverse relation between a reduced lymphocyte count and change in forced vital capacity and isotope uptake on a gallium scan. These correlations were too weak to make repeated cell counts useful in management. Our results suggest that high intensity alveolitis may be a favourable prognostic factor for lung function in pulmonary sarcoidosis, even in patients with chronic disease, but that repeat lavage adds little to the management of the individual patient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2588210      PMCID: PMC462054          DOI: 10.1136/thx.44.9.732

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  18 in total

1.  Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?

Authors:  M Turner-Warwick; W McAllister; R Lawrence; A Britten; P L Haslam
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

2.  Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis.

Authors:  A Nosal; L A Schleissner; F S Mishkin; J Lieberman
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

3.  Bronchoalveolar lavage cell analysis in sarcoidosis. A comparison of lymphocyte counts and clinical course.

Authors:  S Buchalter; W App; L Jackson; D Chandler; R Jackson; J Fulmer
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

4.  Gallium-67 scintigraphy, bronchoalveolar lavage, and pathologic changes in patients with pulmonary sarcoidosis.

Authors:  S Abe; M Munakata; M Nishimura; Y Tsuneta; T Terai; I Nakano; Y Ohsaki; Y Kawakami
Journal:  Chest       Date:  1984-05       Impact factor: 9.410

5.  Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy.

Authors:  R P Baughman; M Fernandez; C H Bosken; J Mantil; P Hurtubise
Journal:  Am Rev Respir Dis       Date:  1984-05

6.  The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function.

Authors:  B A Keogh; G W Hunninghake; B R Line; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1983-08

7.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

8.  Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis.

Authors:  R A DeRemee; M S Rohrbach
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

9.  Persistent high alveolar lymphocytosis as a predictive criterion of chronic pulmonary sarcoidosis.

Authors:  D Israel-Biet; A Venet; J Chrétien
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

Review 10.  Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease.

Authors:  R P Daniele; J A Elias; P E Epstein; M D Rossman
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

View more
  3 in total

1.  Comparison of pulmonary thin section CT findings and serum KL-6 levels in patients with sarcoidosis.

Authors:  K Honda; F Okada; Y Ando; H Mori; K Umeki; H Ishii; J Kadota; M Ando; E Miyazaki; T Kumamoto
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

2.  Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph.

Authors:  A Tazi; T Desfemmes-Baleyte; P Soler; D Valeyre; A J Hance; J P Battesti
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

Review 3.  Sacroiliitis in sarcoidosis: case reports and review of the literature.

Authors:  I Kötter; H Dürk; J G Saal
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.